CooperCompanies stock holds firm after June quarter beat
Published on 08/27/2026 at 21:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CooperCompanies (US21664P1039) is trading around $72.68, with a $14.17 billion market value and a 52-week range of $58.89 to $89.83 as of August 27, 2026. The medical device group also posted June 4, 2026 quarter revenue of $1.08 billion and earnings of $1.21 per share, both above the $1.05 billion and $1.10 estimates in the same earnings snapshot.
June quarter still sets the tone
The latest quarterly comparison is straightforward: revenue rose 7.9% year over year, while EPS improved from $0.96 a year earlier to $1.21. That mix matters because the market is still pricing a company whose FY 2026 guidance sits at $4.58 to $4.66 a share, with analysts at $4.63 for the year.
For investors, the gap between the reported quarter and the full-year range is small enough to keep execution front and center. A quarter at $1.21 EPS and a consensus of $4.63 for FY 2026 leaves little room for a clear slowdown.
Valuation does the talking
At 61.59 times earnings, the stock still carries a premium multiple against a 0.83 beta. The current setup suggests the shares are being judged less on a single quarter and more on whether Cooper can keep converting that $1.08 billion revenue base into steady margin support.
The stock's 52-week band from $58.89 to $89.83 gives a useful reference point for the current $72.68 level. That leaves the shares between the low and high, with the market cap at $14.17 billion anchoring the valuation discussion.
Contact lenses and diagnostics
Cooper's two main businesses remain contact lenses and fertility and womens' health diagnostics, with brands such as CooperVision and CooperSurgical carrying the operating story. Those product lines matter because the reported June quarter beat came from a business that still relies on recurring demand rather than one-off demand spikes.
Price and setup
As of August 27, 2026, CooperCompanies trades at $72.68, and the market has it positioned closer to the midpoint of its 52-week band than to either extreme.
Company facts
Company: The Cooper Companies, Inc.
ISIN: US21664P1039
Ticker: COO
Exchange: Nasdaq
Sector / Industry: Health Care / Medical Instruments & Supplies
Index membership: S&P 500
Price (as of August 27, 2026): $72.68 USD
Market cap: $14.17 billion
Next earnings date: September 9, 2026
